Patents by Inventor Nadia Rupniak

Nadia Rupniak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stigmine Conjugates for Substance Use Disorders
    Publication number: 20110251175
    Abstract: The invention relates to methods for the treatment or prevention of substance use disorders.
    Type: Application
    Filed: July 16, 2009
    Publication date: October 13, 2011
    Inventors: Nadia Rupniak, James F. White
  • Method for treating or preventing psychosomatic and psychoimmunologic disorders
    Patent number: 6573261
    Abstract: This invention relates to the use of a tachykinin receptor antagonist for treating a psychosomatic or a psychoimmunological disorder in a patient.
    Type: Grant
    Filed: May 15, 2001
    Date of Patent: June 3, 2003
    Assignee: Merck & Co., Inc.
    Inventors: Nadia Rupniak, Mark S. Kramer
  • Method for treating premenstrual or late luteal phase syndrome
    Publication number: 20020142942
    Abstract: A tachykinin receptor antagonist is useful for alleviating or managing symptoms associated with premenstrual syndrome in a woman, in particular, for the treatment or prevention of disturbances of appetite, disturbances of mood, or both, associated with premenstrual syndrome.
    Type: Application
    Filed: March 25, 2002
    Publication date: October 3, 2002
    Applicant: Merck & Co. Inc.
    Inventors: Bennett M. Shapiro, Nadia Rupniak
  • Method for treating or preventing psychosomatic and psychoimmunologic disorders
    Publication number: 20010029244
    Abstract: A tachykinin receptor antagonist is useful for treating or preventing a psychosomatic or a psychoimmunological disorder in a patient.
    Type: Application
    Filed: May 15, 2001
    Publication date: October 11, 2001
    Applicant: Merck & Co., Inc.
    Inventors: Nadia Rupniak, Mark S. Kramer
  • Method for treating attention deficit disorder
    Patent number: 6242446
    Abstract: Tachykinin receptor antagonists that are useful for treating or preventing attention deficit disorder, optionally associated with hyperactivity in a patient, are desclosed.
    Type: Grant
    Filed: May 31, 2000
    Date of Patent: June 5, 2001
    Assignee: Merck & Co., Inc.
    Inventors: David L. Glatt, Mark S. Kramer, Nadia Rupniak
  • Method for treating or preventing psychosomatic and psychoimmunologic disorders
    Patent number: 6232311
    Abstract: A tachykinin receptor antagonist is useful for treating or preventing a psychosomatic disorder in a patient.
    Type: Grant
    Filed: August 10, 1999
    Date of Patent: May 15, 2001
    Assignee: Merck & Co., Inc.
    Inventors: Nadia Rupniak, Mark S. Kramer
  • Method for treating attention deficit disorder
    Patent number: 6121261
    Abstract: A tachykinin receptor antagonist is useful for treating or preventing attention deficit disorder, optionally associated with hyperactivity, in a patient.
    Type: Grant
    Filed: November 19, 1998
    Date of Patent: September 19, 2000
    Assignee: Merck & Co., Inc.
    Inventors: David L. Glatt, Mark S. Kramer, Nadia Rupniak
  • Method for treating or preventing psychoimmunological disorders
    Patent number: 5972938
    Abstract: A tachykinin receptor antagonist is useful for treating or preventing a psychoimmunological disorder in a patient.
    Type: Grant
    Filed: November 25, 1998
    Date of Patent: October 26, 1999
    Assignee: Merck & Co., Inc.
    Inventors: Nadia Rupniak, Mark S. Kramer